-
Celgene Is A Must-Own Stock
Post on 4/27/17
-
Johnson & Johnson's Medical Device Business: What Investors Need to Know
Post on 4/27/17
-
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post on 4/26/17
-
Xerox (XRX) Q1 2017 Results - Earnings Call Transcript
Post on 4/26/17
-
3 Reasons Pfizer Is a Better Dividend Stock Than Bristol-Myers Squibb
Post on 4/26/17
-
J&J Snack Foods Corp's (JJSF) CEO Gerald Shreiber on Q2 2017 Results - Earnings Call Transcript
Post on 4/26/17
-
Better Buy: Celgene Corporation vs. Merck & Co., Inc.
Post on 4/26/17
-
Here's Why Risk-Averse Investors May Want to Think Twice About Buying Johnson & Johnson
Post on 4/26/17
-
Q BioMed Announces Licensing Agreement for Development of Drug to Treat Rare Pediatric Disorder
Post on 4/25/17
-
Merck: Strong Research And Bolt-On Acquisitions
Post on 4/25/17
-
Better Buy: Amgen Inc. vs. Pfizer
Post on 4/25/17
-
Were Johnson & Johnson's Earnings Really That Bad?
Post on 4/25/17
-
Data Diagnostics Wins Gold at the 30th Annual Edison Awards
Post on 4/24/17
-
Novartis Expands Global Collaboration with Amgen
Post on 4/24/17
-
McCann Echo Named Agency of the Year
Post on 4/24/17
-
Diaceutics Signs Multi-Million-Dollar Partnership with BioReference Laboratories
Post on 4/24/17
-
ShopRite Joins Aetna’s Preferred Medicare Pharmacy Network
Post on 4/24/17
-
Merck Leads Rivals In Novel Drug Approvals
Post on 4/24/17
-
Johnson & Johnson: Modest Price Decline Presents Buying Opportunity
Post on 4/24/17
-
3 Things Johnson & Johnson Didn't Tell You in Its Q1 Earnings Update
Post on 4/24/17
-
Better Buy: AbbVie Inc. vs. Pfizer
Post on 4/24/17
-
Edison Awards Recognize Ortho Clinical Diagnostics for Outstanding Product Innovation
Post on 4/23/17
-
Pfizer: Relatively High Yield Healthcare Blue Chip
Post on 4/21/17
-
Better Buy: Verizon Communications Inc. vs. Johnson & Johnson
Post on 4/21/17
-
Bristol-Myers Squibb Co: Buy the Dip?
Post on 4/21/17
New York
